MIR8071-2

Across TCGA pan-cancer cohorts, MIR8071-2 RNA is linked to patient survival in 26 of 34 cancer types, making it the most broadly survival-associated MIR8071-2 data layer.

The strongest signal is observed in head and neck squamous cell carcinoma (HNSC), where higher MIR8071-2 RNA is associated with better overall survival. In most high-consensus cancer types, elevated MIR8071-2 expression acts as an unfavorable survival marker, although some lineages such as HNSC and SKCM show a favorable association.

HNSC, SKCM, and LIHC are the cancer types where MIR8071-2 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
HNSC	OS	Median	All	0.720	0.600	<.001	149	view →
SKCM	OS	Tertile	All	0.831	0.717	<.001	70	view →
LIHC	DFS	Median	All	0.374	0.231	.001	56	view →
UVM	OS	Tertile	II,III,IV	0.199	0.743	<.001	45	view →
LUAD	DFS	Median	All	0.832	0.750	.005	38	view →
DLBC	DFS	Quartile	III,IV	0.159	0.917	.006	37	view →
LGG	DFS	Median	All	0.281	0.468	<.001	36	view →
CESC	OS	Quartile	All	0.948	0.816	.004	30	view →
ACC	DFS	Tertile	III,IV	0.010	0.364	<.001	27	view →
COAD	OS	Median	IV	0.851	0.284	.001	25	view →
READ	DFS	Median	IV	0.885	0.387	.007	24	view →
CHOL	DFS	Median	All	0.762	0.120	.002	21	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 26 lineages.

MIR8071-2–HNSC (OS)

Open the HNSC breakdown →